FDA Approved: SPRINTEC — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for SPRINTEC, a combination oral contraceptive containing norgestimate and ethinyl estradiol, from Teva Pharmaceuticals …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• SPRINTEC (NORGESTIMATE AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for SPRINTEC (NORGESTIMATE AND ETHINYL ESTRADIOL)